Rheumnow Podcast-logo

Rheumnow Podcast

Health & Wellness Podcasts

Here and now

Here and now

Location:

United States

Description:

Here and now

Language:

English

Contact:

6822290477


Episodes

Rheum Manpower Needs - More Programs! (12.2.2022)

12/2/2022
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com

Duration:00:21:26

Biologics in Lupus – Why, Who, and When? Sponsored by GSK US Medical Affairs

12/1/2022
Leading experts from the SLE Educators’ Network discuss how biologic therapies may help address key unmet needs in lupus, while highlighting how clinicians can identify the most appropriate patients for biologic treatment.

Duration:00:21:26

Topic Podcasts - JAK TYK2

11/20/2022
ACR22 Year in Review Report Deucravacitinib in PsA JAK inhibitors in rheumatic diseases JAK vs TNF inhibitor Infections in RA New Treatments for SLE? Prelude to a Meeting (ACR22) (11.11.2022) Switching Between JAK Inhibiters in RA Tapering Methotrexate with Biologics or JAK Inhibitors in RA Tofacitinib and RA-ILD Upadacitinib vs Adalimumab in PsA using RAPID3

Duration:00:54:14

Topic Podcasts - Lupus Part3

11/20/2022
Addressing Sexual Health and STD Prevention in Lupus Patients CAR-T Therapies in Antiphospholipid Antibody Syndrome Copays Reduce Adherence to SLE Medications Diffuse alveolar hemorrhage in antiphospholipid syndrome Hydroxychloroquine Update from ACR22 Low-grade Proteinuria in Non Renal Lupus: Should We be Worried? Photovoice: A New Visual Research Method in Lupus Stop Ordering Repeat ANAs! Timely Fetal Screening Important in Positive Anti-Ro Antibody Pregnancies Life or Organ Threatening...

Duration:01:04:45

Topic Podcasts - Lupus Part2

11/20/2022
ACR22 Daily Recap: Saturday Recap New Treatments for SLE?

Duration:00:41:03

Topic Podcasts - Lupus Part1

11/20/2022
A Novel Treatment Response Measurement Tool for Lupus ACR22 Year in Review Report Breakthrough COVID infection in SLE during Omicron era Effect of voclosporin in class V lupus nephritis Lupus, Sex and STDs Poor Medication Adherence in SLE and How to Improve It Prelude to a Meeting (ACR22) (11.11.2022) Should You Repeat the ENA Panel? Urinary Biomarkers in Lupus Urine Proteomics in SLE with Dr. Michelle Petri

Duration:01:11:22

Topic Podcasts - PsA Part3

11/19/2022
Sunday (Day 2): ACR 22 Daily Recap

Duration:00:41:03

Topic Podcasts - PsA Part2

11/19/2022
ACR 2022 Appraisal, Praise & Critique (11.18.2022) Best of ACR Day Two in PSA Efficacy and Safety Results from BE OPTIMAL in PsA JAK inhibitors in rheumatic diseases Oligoarticular PsA: FOREMOST Study Opioid use in PsA and SpA PET CT Imaging to Define Risk of Progression from PSO to PsA PsA and SPA: Cyclers, Switchers, Who is the Winner? Switch vs Cycle in PsA Women vs. Men: Response to Treatment in Seronegative Arthritis

Duration:00:47:25

Topic Podcasts - PsA Part1

11/19/2022
Best of PsA on Day 1 Can computers tell the difference between RA & PsA? Deucravacitinib in PsA Differences in Presentation and Outcomes of Early vs Late Onset PsA Opioids and Health Care Utilization in PsA and AS Patient Reported Outcomes in PsA Using Novel IL 17A Inhibitor PsA Cycling or Switching MOAs The Dietary Intervention in PsA (DIPSA) Study Ultrasound in PsA Upadacitinib vs Adalimumab in PsA using RAPID3

Duration:00:34:20

Topic Podcasts - RA Part4

11/19/2022
Sunday (Day 2): ACR 22 Daily Recap

Duration:00:41:03

Topic Podcasts - RA Part3

11/19/2022
Bouncebackability portends increased risk of adverse outcomes in RA Can I stop Methotrexate in RA? Fat and bone are never alone: osteoporotic fracture in RA JAK inhibitors in rheumatic diseases RA: Steroids are bad, again Reproductive health in a post-Roe world Sensor-engineered glove evaluates hand function in RA Tapering Methotrexate with Biologics or JAK Inhibitors in RA Tofacitinib and RA-ILD

Duration:00:28:00

Topic Podcasts - RA Part2

11/19/2022
ACR22 Daily Recap: Saturday Recap JAK vs TNF inhibitor Infections in RA Opioid and Neuropathic Use After Initiating btsDMARDs in RA Pre-RA Pharmacological Interventions: Delaying is not Enough PreRA to Treat or Not! Prescribing Methotrexate in Post-Roe Era The Great Debate: To Treat or Not to Treat Pre RA To Switch or Not: Biosimilars in Inflammatory Arthritis

Duration:00:50:51

Topic Podcasts - RA Part1

11/19/2022
ACR22 Year in Review Report Can computers tell the difference between RA & PsA? NSAIDs and CV risk in Inflammatory Arthritis Prelude to a Meeting (ACR22) (11.11.2022) QD205 - RA Activity During Pregnancy (abstract #0955) Sputum anti-CCP the new diagnostic test in at-risk RA? Switching Between JAK Inhibiters in RA Treatment Choices and Mortality in RA ILd

Duration:00:47:23

Topic Podcasts ACR2022 - SpA Part4

11/19/2022
Treatment Considerations in Axial Spondyloarthritis What Happens after you stop biologics? What lifestyle factors affect TNF inhibitor efficacy in AxSpA? Which is better for AxSpA? IL-17i or TNFi? Women vs. Men: Response to Treatment in Seronegative Arthritis

Duration:00:20:38

Topic Podcasts ACR2022 - SpA Part3

11/19/2022
Opioids and Health Care Utilization in PsA and AS Reproductive health in a post-Roe world Spondyloarthritis: Novel Therapies, Diagnostic Dilemmas and Depression Sunday (Day 2): ACR 22 Daily Recap Tapering TNFi in nonradiographic AxSpA The CONSUL Trial: Ankylosing Spondylitis

Duration:01:01:45

Topic Podcasts ACR2022 - SpA Part2

11/19/2022
Comorbidities in Ankylosing Spondylitis Early Diagnosis of Axial Spondyloarthritis Fertility issues in SpA Gender in AxSpa Inadequate Dosing of Hydroxychloroquine Leads to Hospitalizations in SLE JAK inhibitors in rheumatic diseases Opioid use in PsA and SpA

Duration:01:15:04

Topic Podcasts ACR2022 - SpA Part1

11/19/2022
ACR22 Daily Recap: Saturday Recap AI Future of Sacroiliitis Assessment Artificial Intelligence in Detecting Sacroiliitis Axial Spondyloarthritis: gender differences Can we alter neonatal gut microbiome to prevent spondyloarthritis? Comorbidities in Axial Spondyloarthritis Do Disease Activity Measures Really Capture AS in Women?

Duration:00:54:02

RheumNow Rheumatology Roundup

11/18/2022
Dr. Jack Cush and Dr. Arthur Kavanaugh discuss, dissect and deliberate the sessions and data presented at the ACR22 meeting in Philadelphia.

Duration:01:01:32

ACR 2022 Appraisal, Praise & Critique (11.18.2022)

11/18/2022
ACR 2022 Appraisal, Praise & Critique (11.18.2022) by Dr. Cush

Duration:00:20:05

Spondyloarthritis Topic Panel - ACR22

11/17/2022
Wednesday - SpA Panelists: Drs. Lianne Gensler, Antoni Chan, Akhil Sood, Eric Dein, Sheila Reyes, Catherine Sims

Duration:00:34:23